Composition
- Active ingredients
- ENASIDENIB MESYLATE EQ 50MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ENASIDENIB MESYLATE EQ 100MG BASE · TabletNDA209606-002 · Prescription
- ENASIDENIB MESYLATE EQ 50MG BASE · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209606.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Idhifa
- Active substance
- enasidenib mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Bristol Myers Squibb
- Status
- Prescription
- FDA approval
- 1 Aug 2017
- Application
- NDA209606-001